MSD Global Health Innovation Fund, a corporate venture capital arm of Merck & Co., Inc., Rahway, NJ, USA, who became an Evaxion shareholder in December 2023, is also participating in this offering ...
COPENHAGEN - Ringkjøbing Landbobank has announced the launch of a new share buyback program, effective today, with the intent to acquire up to DKK 500 million worth of its own shares. The program, ...
Notification no. 8/2025 Transactions made by persons obliged to report transactions to the Danish FSA and Nasdaq Copenhagen, cf. the EU Market Abuse Regulation. In connection with the share buy-back ...
The share buyback programme will be implemented in compliance with Regulation (EU) No 596/2014 of the European Parliament and ...
Following a constructive Nasdaq hearing panel on January 7, 2025, Evaxion has been granted a 180-day extension in relation to the Nasdaq minimum ...
Transactions in connection with share buyback programmeOn 04 December 2024, Tryg A/S (“Tryg”) announced that the Board of ...
The publication can be found here: Determination of Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) Reference Intervals in Healthy Adult and Pediatric Individuals Using a Particle-Enhanced ...